MYH9 and central nervous system cancer: MYH9 knockdown inhibited glioma cell migration and invasion, even when THBS1 was overexpressed (Fig. 7B, C), indicating that the effect of apatinib on glioma cells likely involves the THBS1/MYH9 axis.